ATAI - Company ID 0001840904
The table below shows ATAI Life Sciences N.V.'s income statement line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Revenue | $308.00K | $314.00K | $233.00K | $20.38M | $0.00 |
| Cost of revenue | - | - | - | - | - |
| Gross profit | - | - | - | - | - |
| R&D | $400.00K | $2.00M | $2.80M | - | - |
| SG&A | $47.54M | $63.58M | $70.35M | $92.75M | $80.73M |
ATAI Life Sciences N.V. reported annual revenue of $308.00K for fiscal year 2024. That is down 1.9% from $314.00K in fiscal 2023. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Operating income |
| -$102.69M |
| -$125.47M |
| -$144.79M |
| -$135.81M |
| -$104.16M |
| Income tax | -$356.00K | $1.02M | $6.23M | $3.99M | $305.00K |
| Net income | -$149.27M | -$40.22M | -$152.38M | -$167.81M | -$169.84M |
| EPS (diluted) | -$0.93 | -$0.25 | -$0.98 | -$1.21 | - |